Showing results (1-10 of 271) with videos related to
Sort By:
Pageof 28
Therapeutic Drug Monitoring|January 1, 1982
Evaluation of three gentamicin serum assay techniquesG R Matzke, C Gwizdala, J Wery, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agentsG R MatzkeThe Annals of Pharmacotherapy|February 1, 1997
Clinical consequences of nonnarcotic analgesic useG R MatzkeAntimicrobial Agents and Chemotherapy|March 1, 1983
Cefsulodin pharmacokinetics in patients with various degrees of renal functionG R Matzke, W F KeaneAmerican Journal of Hospital Pharmacy|October 1, 1981
Nephropathy as a hazard of analgesic abuseJ V Anandan, G R MatzkeTherapeutic Drug Monitoring|January 1, 1984
Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatographyR J Sawchuk, G R MatzkeDrug Intelligence & Clinical Pharmacy|October 1, 1987
Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesicsG L Chan, G R MatzkeDrug Intelligence & Clinical Pharmacy|May 1, 1981
Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassayG R Matzke, R J SawchukDrug Safety|March 1, 1997
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicityG R Matzke, R F FryePageof 28